HomeENLV • NASDAQ
add
Enlivex Therapeutics Ltd
Previous close
$0.89
Day range
$0.85 - $0.89
Year range
$0.81 - $1.84
Market cap
19.52M USD
Avg Volume
121.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.48M | -10.01% |
Net income | -5.18M | 43.09% |
Net profit margin | — | — |
Earnings per share | -0.23 | 52.08% |
EBITDA | -5.44M | 7.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.50M | -14.00% |
Total assets | 27.69M | -24.83% |
Total liabilities | 4.10M | -39.26% |
Total equity | 23.59M | — |
Shares outstanding | 23.65M | — |
Price to book | 0.89 | — |
Return on assets | -47.67% | — |
Return on capital | -53.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.18M | 43.09% |
Cash from operations | -4.08M | 22.61% |
Cash from investing | 3.36M | -18.79% |
Cash from financing | 1.26M | — |
Net change in cash | 535.00K | 146.85% |
Free cash flow | -1.28M | 79.49% |
About
Founded
Jan 22, 2012
Website
Employees
49
